CC BY-NC-ND 4.0 · Rev Bras Ortop (Sao Paulo) 2019; 54(06): 636-643
DOI: 10.1016/j.rboe.2018.03.002
Artigo Original
Sociedade Brasileira de Ortopedia e Traumatologia. Published by Thieme Revnter Publicações Ltda Rio de Janeiro, Brazil

Platelet-Rich Plasma and Corticosteroid in the Treatment of Rotator Cuff Impingement Syndrome: Randomized Clinical Trial[*]

Article in several languages: português | English
Ronald Bispo Barreto
1  Departamento de Medicina, Universidade Tiradentes, Aracaju, SE, Brasil
,
2  Medicina Fisica e Reabilitação, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, SP, Brasil
,
Mayvelise Correia de Gois
1  Departamento de Medicina, Universidade Tiradentes, Aracaju, SE, Brasil
,
Marianna Ribeiro de Menezes Freire
1  Departamento de Medicina, Universidade Tiradentes, Aracaju, SE, Brasil
,
Denison Santos Silva
1  Departamento de Medicina, Universidade Tiradentes, Aracaju, SE, Brasil
,
Juliana Cordeiro Cardoso
3  Programa de pós-graduação em Saúde e meio ambiente, Universidade Tiradentes, Aracaju, SE, Brasil
› Author Affiliations
Further Information

Publication History

12 November 2017

27 February 2018

Publication Date:
13 December 2019 (online)

Abstract

Objective This research aims to study the effectiveness of platelet-rich plasma (PRP) in the treatment of patients with rotator cuff impingement syndrome compared with the treatment with subacromial injection of corticosteroids.

Methods This is a double-blind, randomized, comparative clinical trial. The patients were clinically evaluated with the use of the Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure, University of California Los Angeles (UCLA) shoulder rating scale and Constant-Murley shoulder outcome score (CMS) on the day of application, and then again after 1, 3 and 6 months.

Results No statistically significant differences were found (p < 0.05) when comparing the results of the DASH outcome measure, UCLA shoulder rating scale and CMS of the two groups at baseline and after 1, 3, and 6 months of treatment with subacromial injection. After the treatment, both groups showed a significant improvement in the DASH and UCLA scores (p < 0.05) when compared with the baseline. However, the CMS at 6 months after treatment with steroids was lower than the baseline.

Concusions These findings suggest that PRP is a safe treatment and can be a useful tool in the therapeutic arsenal against of the rotator cuff diseases, for there was no significant difference between the subacromial use of PRP and corticosteroids.

* Work performed at DeCós Day Hospital, Aracaju, SE, Brazil. Originally Published by Elsevier Editora Ltda.